ORMP — Oramed Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $171.80m
- $121.19m
- $2.00m
Brief: Oramed Pharmaceuticals Announces The Buy-Back Of Its Common Stock
Brief: Oramed Pharmaceuticals Inc - On June 6, Appointed Avraham Gabay To Serve As CFO, Treasurer And Secretary
Oramed Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Oramed Pharmaceuticals Inc expected to post earnings of 2 cents a share - Earnings Preview
Brief: Oramed Pharmaceuticals Says On May 2, Co Received Additional Payment Of About $9.6 Million Pursuant To Terms Of Note
Brief: Oramed Pharmaceuticals On March 18 Entered Into An At Market Offering Agreement
Oramed Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Oramed Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Oramed Pharmaceuticals And Unit Entered Into Joint Venture Agreement With Hefei Tianhui Biotech And Technowl
Brief: Oramed Pharmaceuticals Increases Board Size By One, Appoints Daniel Aghion
Brief: Oramed Pharmaceuticals Inc-On August 4 Entered Non-Binding Term Sheet With Sorrento Therapeutics
U.S. STOCKS ON THE MOVE-Waters Corp, Parson, Xylem
U.S. STOCKS ON THE MOVE-e.l.f. Beauty, Yum Brands, Nikola
U.S. STOCKS ON THE MOVE-Vertiv Holdings, Emerson Electric, Intercept Pharma
Oramed rises on tie-up for oral insulin delivery tech
Brief: Oramed And HTIT To Create A Joint Venture To Advance Oral Drug Delivery Technology Globally
U.S. RESEARCH ROUNDUP-Magellan Midstream Partners LP, Onsemi, Viking Therapeutics
U.S. STOCKS ON THE MOVE-Verizon Communications, Home Depot, Catalent
U.S. STOCKS ON THE MOVE-Oramed, Fisker, Blue Bird